Bottom line
Is CAPE a good fund? The bottom line
CAPE is an actively managed large blend ETF from Doubleline.
Annual fees run 0.65% — about $65 a year on every $10,000 invested, cheaper than 67% of large blend funds we track.
It returned +9.0% over one year (as of Dec 31, 2025, per its prospectus).
With $238 million in net assets and 182 holdings, its largest position is Eli Lilly & Co. (4.4%) and the top 10 make up 26.3% of the portfolio.
What to watch
- High turnover (255% a year) can mean more taxable distributions
Updated Nov 19, 2026
What CAPE invests in
The Funds investment objective is to seek total return which exceeds the total return of the S&P 500 Index.
Under normal circumstances, the Fund invests at least 80% of its net assets (plus the amount of any borrowings for investment purposes) in U.S. equity securities, including exchange-traded investment companies that provide exposure to U.S. equity securities, subject to the limitations described below. Under normal market conditions, the Fund invests its assets in securities that are listed on a national securities exchange registered with the Securities and Exchange Commission (the SEC ), and that trade contemporaneously with the Funds shares. The Fund may invest in equity securities of companies of any market capitalization other than penny stocks. An issuer is considered to be a U.S. equity issuer if: (i) its principal place of business is located in the United States; (ii) at least 50% of its assets are located in the United States and/or (iii) it derives at least 50% of its…
From the fund's prospectus (filed Jan 27, 2026).
CAPE performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| CAPE | +9.0% | — | — |
| Large Blend median | +13.8% | +9.7% | +10.9% |
Source: Fund prospectus, as of Dec 31, 2025
What CAPE costs
On a $10,000 investment, CAPE's 0.65% expense ratio costs about $65 a year. The prospectus estimates $810 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.
CAPE top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Eli Lilly & Co. | 4.38% |
| 2 | Meta Platforms, Inc. | 3.15% |
| 3 | Johnson & Johnson | 2.81% |
| 4 | Welltower, Inc. | 2.66% |
| 5 | Walmart, Inc. | 2.64% |
| 6 | Alphabet, Inc. | 2.33% |
| 7 | Costco Wholesale Corp. | 2.22% |
| 8 | Prologis, Inc. | 2.18% |
| 9 | AbbVie, Inc. | 2.03% |
| 10 | Alphabet, Inc. | 1.85% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 26.3% of the fund. See all top 25 holdings and asset mix →